BMS-688521

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBMS-688521
Drug Alias NameBMS-688521
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-L/beta-2 (LFA-1) antagonists
TargetsIntegrin alpha-L/beta-2 (LFA-1)
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A